Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Indian patient.
Artykuły w czasopismach na temat „Indian patient”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Indian patient”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
1
Jackson, James G., Sheetal Moolambally Raj, Yulia Matveeva, Yinghui Xu i Gerald J. Jogerst. "US, Russian and Indian physician perspectives regarding end of life care". Russian Family Doctor 24, nr 3 (11.12.2020): 11–20. http://dx.doi.org/10.17816/rfd41869.
Pełny tekst źródłaStreszczenie:
Aim. To compare US, Russian and Indian primary care physicians attitudes, comfort and experiences providing palliative care.
Design. Cross sectional survey.
Settings. Iowa, USA; Leningrad Oblast, Russia; Mangalore, India.
Participants. Primary care physicians.
Methods. Chi-squared testing for dichotomous variables and t-tests for mean scores.
Results. 66 US, 81 Russian and 95 Indian physicians completed the survey. More US physicians preferred end of life care at home (83% v 56% Russian and 29% Indian) p 0.001 and Indian physicians preferring hospitals (36% v 0% US and 1% Russian) p 0.001. 94% percent of US physicians preferred patient make their own decisions, 57% of Russian sample preferred physicians as decision makers, and Indian physicians preferred family members to patients themselves (44%) p 0.001. Patient should be informed (US vs Russia vs India) of terminal illness Always (74% vs 31% vs 33%) p 0.001, If Asked (9% vs 64% vs 12%) p 0.001 or Physicians Judgement (15%, 5%, 54%) p 0.001. US physicians reported higher comfort rates with managing symptoms at the end of life. In the last 6 months US physicians were more satisfied with provided care Often or Always (63% vs 36% Russian v 21% Indian) p 0.001.
Conclusions. US sample was more concerned with patient autonomy and had more comfort and satisfaction in providing end of life care compared to Russian and Indian samples.
2
Gachupin, Francine C., Charlotte A. Garcia i Michael D. Romero. "An American Indian Patient Experience". Journal of Health Care for the Poor and Underserved 30, nr 4S (2019): 62–65. http://dx.doi.org/10.1353/hpu.2019.0116.
Pełny tekst źródła
3
Bhowmick, Subhrojyoti, Snigdha Banerjee, Saibal Das, Abhishek Nath, Debarati Kundu, Anupam Das, Nina Das, Krishnangshu Ray i Sujit Kar Purkayastha. "Awareness and understanding among patients about patient safety in India: A cross-sectional questionnaire-based study". Journal of Patient Safety and Risk Management 27, nr 1 (5.01.2022): 21–25. http://dx.doi.org/10.1177/25160435211065672.
Pełny tekst źródłaStreszczenie:
Background There is a dearth of studies from India evaluating the awareness of patient safety. This study was performed to gain insight into the Indian patients’ awareness about patient safety and evaluate their willingness in promoting the same. Methods In this cross-sectional study, online interactive sessions pertaining to patient safety and patient safety culture were arranged by clinical pharmacologists for 800 urban patients post-discharge from a tertiary care hospital in India. A validated questionnaire was used, and the responses were analysed using descriptive statistics. Results A total of 635 patients [mean age, 43.2 ± 10.3 years; 385 (60.6%) males] responded. A total of 93.4% of the patients were aware of the term “patient safety” and 35.3% faced situations where they felt that patient safety was compromised. Of these patients, 64.3% reported to higher authorities when faced with such situations, while the remaining either ignored the issue or had no idea about how to deal with the same. A total of 99.2% of the patients never participated in any patient safety program; nevertheless, 94.5% of them were willing to participate in the same. Accessibility to information about patient care was deemed essential by 58.3% of the patients. Conclusions Although the overall awareness about patient safety among urban Indian patients is high, there is a lack of awareness about ways of dealing with patient safety issues. Given the high level of interest in participating in patient safety programs, such programs should routinely include patients for optimizing the chances for safer provision of health care.
4
Masih, Suzena, Amita Moirangthem i Shubha R. Phadke. "Renpenning syndrome in an Indian patient". American Journal of Medical Genetics Part A 182, nr 2 (16.12.2019): 293–95. http://dx.doi.org/10.1002/ajmg.a.61457.
Pełny tekst źródła
5
Parthasarathi, Gurumurthy, Madhan Ramesh, Karin Nyfort-Hansen i Bahubali Gundappa Nagavi. "Clinical Pharmacy in a South Indian Teaching Hospital". Annals of Pharmacotherapy 36, nr 5 (maj 2002): 927–32. http://dx.doi.org/10.1345/aph.1a223.
Pełny tekst źródłaStreszczenie:
OBJECTIVE: To describe how clinical pharmacy is helping to improve medication use at a South Indian teaching hospital by addressing medication use problems, which are commonly encountered in India. SUMMARY: Clinical pharmacy is practiced in many countries and makes a significant contribution to improved drug therapy and patient care. India is a country with significant problems with medication use, but until recently Indian pharmacists have not been educated for a patient-care role. Postgraduate pharmacy practice programs have been established at 2 pharmacy colleges in South India as a result of a joint Indo-Australian program of cooperation. At a teaching hospital associated with the colleges, clinical pharmacy services such as drug information, medication counseling, drug therapy review, adverse drug reaction reporting, and the preparation of antibiotic guidelines are assisting clinicians to improve drug therapy and patient care. Seven hundred twenty-seven requests for drug information were received from July 1997 to February 2001, and 543 suspected adverse drug reactions were evaluated from November 1997 to February 2001. The most common drug classes causing adverse drug reactions were antibiotics, nonsteroidal antiinflammatory drugs, and antitubercular agents. Physician opinion and service utilization have also been surveyed: 82% of respondents had sought drug information from the Clinical Pharmacy Department and 71% of respondents had sought advice on individual patient management. The success of this program is raising awareness of clinical pharmacy among pharmacy educators elsewhere in India and has led to the introduction of clinical pharmacy services at other Indian hospitals.
6
Wijesekera, Olindi, Amanda Reed, Parker S. Chastain, Shauna Biggs, Elizabeth G. Clark, Tamorish Kole, Anoop T. Chakrapani i in. "Epidemiology of Emergency Medical Services (EMS) Utilization in Four Indian Emergency Departments". Prehospital and Disaster Medicine 31, nr 6 (19.09.2016): 675–79. http://dx.doi.org/10.1017/s1049023x16000959.
Pełny tekst źródłaStreszczenie:
AbstractIntroductionWithout a universal Emergency Medical Services (EMS) system in India, data on the epidemiology of patients who utilize EMS are limited. This retrospective chart review aimed to quantify and describe the burden of disease and patient demographics of patients who arrived by EMS to four Indian emergency departments (EDs) in order to inform a national EMS curriculum.MethodsA retrospective chart review was performed on patients transported by EMS over a three-month period in 2014 to four private EDs in India. A total of 17,541 patient records were sampled from the four sites over the study period. Of these records, 1,723 arrived by EMS and so were included for further review.ResultsA range of 1.4%-19.4% of ED patients utilized EMS to get to the ED. The majority of EMS patients were male (59%-64%) and adult or geriatric (93%-99%). The most common chief complaints and ED diagnoses were neurological, pulmonary, cardiovascular, gastrointestinal, trauma, and infectious disease.ConclusionsNeurological, pulmonary, cardiovascular, gastrointestinal, trauma, and infectious disease are the most common problems found in patients transported by EMS in India. Adult and geriatric male patients are the most common EMS utilizers. Emergency Medical Services curricula should emphasize these knowledge areas and skills.WijesekeraO, ReedA, ChastainPS, BiggsS, ClarkEG, KoleT, ChakrapaniAT, AshishN, RajhansP, BreaudAH, JacquetGA. Epidemiology of Emergency Medical Services (EMS) utilization in four Indian emergency departments. Prehosp Disaster Med. 2016;31(6):675–679.
7
Singh, Narinder, Geeta Sharma, Rahat Kumar i Vikram Bhandari. "Pharmacovigilance in India and its Impact in Patient Management". AMEI's Current Trends in Diagnosis & Treatment 1, nr 1 (1.03.2017): 27–33. http://dx.doi.org/10.5005/jp-journals-10055-0006.
Pełny tekst źródłaStreszczenie:
ABSTRACT Pharmacovigilance is the pharmacological science relating to the detection, assessment, understanding, and prevention of adverse effects, particularly the long-term and short-term adverse effects of drugs or treatment. The World Health Organization (WHO) established pharmacovigilance Programme for International Drug Monitoring in response to the thalidomide disaster detected in 1961. India joined the WHO adverse drug reaction (ADR) monitoring program based in Uppsala, Sweden, in 1998. The Central Drugs Standard Control Organization (CDSCO), Directorate General of Health Services, under the aegis of the Ministry of Health and Family Welfare, Government of India, in collaboration with Indian Pharmacopoeia Commission, Ghaziabad, is a National Coordinating Centre (NCC). Adverse drug reaction monitoring centers (AMCs) under the Pharmacovigilance Programme of India (PvPI) play a vital role in the collection and follow-up of ADR reports from the patients, as drug trials in animals and humans (Phase I–III) do not predict accurately the adverse drug events. Patients with chronic kidney disease (CKD)/liver disease are at risk of enhanced drug-related events. These patients should be closely monitored for any adverse events and it should be reported. Thus, inculcating the habit of ADR reporting will help in generating data specific to Indian population and will contribute toward patient safety. This will also help in modifying the treatment given to the patients, as early identification of ADRs will help in reducing morbidity and mortality in patients. How to cite this article Sharma G, Kumar R, Singh J, Bhandari V, Singh N. Pharmacovigilance in India and its Impact in Patient Management. Curr Trends Diagn Treat 2017;1(1):27-33.
8
Lakhtakia, Sundeep, i Mohan Ramchandani. "Triaging Patients Undergoing Endoscopy During COVID-19 Pandemic". Journal of Digestive Endoscopy 11, nr 01 (marzec 2020): 41–43. http://dx.doi.org/10.1055/s-0040-1712270.
Pełny tekst źródłaStreszczenie:
Abstract"Triaging for endoscopy" is the process to determine the most deserving patients after careful scrutiny amongst a pool of patients who report for Gastrointestinal (GI) Endoscopy diagnostic or interventional procedures that include Esophago-gastro-duodenoscopy (OGD), Colonoscopy, ERCP, EUS and Enteroscopy. The purpose of triaging at endoscopy is to prevent transmission of SARS-COV2 infection from suspected patient to the health care workers involved at endoscopy. The three professional Indian Gastroenterology bodies namely Society of Gastrointestinal Endoscopy of India (SGEI), Indian Society of Gastroenterology (ISG) & Indian Association for the study of the liver (INASL) have recently provided guidance of scheduling of endoscopic procedures in the current Covid-9 pandemic. Similar suggestions have been promulgated by other international bodies.
9
Choudhari, Pradeep, Himanshu Bansal i Mayank Kumar. "ANTHROPOMETRIC ANALYSIS OF THE HIP JOINT IN CENTRAL INDIA POPULATION USING COMPUTED TOMOGRAPHY". International Journal of Advanced Research 9, nr 09 (30.09.2021): 108–16. http://dx.doi.org/10.21474/ijar01/13382.
Pełny tekst źródłaStreszczenie:
Background: The presently available hip prosthesis used in hip arthroplasty are designed based on the anthropometry of Western patients. These prosthesis do not replicate the exact anatomy of Indian patients, leading to postoperative complications and requiring revision surgery for correction. If the manufacturers keep in considering the anthropometric parameters of Indians while designing the prosthesis, this may lead to better clinical and functional outcome and higher patient satisfaction. So the present study was undertaken to understand the anthropometric variables of hip joint of Central Indian population and to compare these variables with the other Indian Ethnic groups and western population using computed tomographic images. Materials And Methods: We had included 200 patients and both the left and right side hip joints were analysed. The anthropometric variables included were Neck-Shaft Angle (NSA), Head Diameter (HD), Neck Width (NW), Acetabular Angle of sharp(AA), Horizontal Offset (HO), Vertical Offset (VO), Medullary Canal Diameter at the level of Lesser Trochanter (MDLT), and Acetabular Version (AV) were measured in all these individuals. Comparison of these parameters was done between the left and right side and among the males and females and compared with various populations and statistically analyzed Result: The mean values were NSA 132.53°, NW 25.11 mm, HD 43.94 mm, AA of sharp 43.11°, HO 43.76 mm, VO 56.37 mm, MDLT 23.00 mm, and AV 19.47°. We found a large variations in these parameters among the Indian ethnic groups and western population. Significant differences were seen between the males and females. Conclusion: This study indicates that there are significant differences in anthropometric parameters of proximal femur among the Central India population compared with Western population. Even within the Indian population, the anthropometric parameters vary from region to region.
10
Majumdar, Pradyumna Krishna, Rakesh Kumar Gupta, Raj Singh Potalia, Vinit Verma, Jay Dhariwal, Parth Singh, Karunesh Ranjan i Surinder Jaiswal. "The Remarkable Immunity of the Indian Patient". Indian Journal of Scientific Research 11, nr 2 (31.01.2021): 63. http://dx.doi.org/10.32606/ijsr.v11.i2.00011.
Pełny tekst źródła
11
Gupta, Arvind, Renuka Srinivasan, DattaG Pandian i KRamesh Babu. "Lenz microphthalmic syndrome in an Indian patient". Indian Journal of Ophthalmology 55, nr 6 (2007): 462. http://dx.doi.org/10.4103/0301-4738.36485.
Pełny tekst źródła
12
M, ManavManchanda, HariharanMunganda H, Kumari M, UmaRani R i ShilpaGupta S. "PULMONARY COCCIDIOIDIOMYCOSIS IN AN INDIAN IMMUNOCOMPETENT PATIENT." International Journal of Advanced Research 5, nr 7 (31.07.2017): 1273–82. http://dx.doi.org/10.21474/ijar01/4838.
Pełny tekst źródła
13
Singh, Sarman. "Mucosal leishmaniasis in an Indian AIDS patient". Lancet Infectious Diseases 4, nr 11 (listopad 2004): 660–61. http://dx.doi.org/10.1016/s1473-3099(04)01179-x.
Pełny tekst źródła
14
Kanwar, AmrinderJ, Surrinder Kaur, Rend Bansal, BishanD Radotra i Rajeev Sharma. "Sulzberger-Garbe Dermatosis in an Indian Patient". International Journal of Dermatology 28, nr 1 (styczeń 1989): 44–45. http://dx.doi.org/10.1111/j.1365-4362.1989.tb01311.x.
Pełny tekst źródła
15
Chiang, Pei-Wen, Elaine Spector i Angela Scheuerle. "A case of Asian Indian OCA3 patient". American Journal of Medical Genetics Part A 149A, nr 7 (lipiec 2009): 1578–80. http://dx.doi.org/10.1002/ajmg.a.32930.
Pełny tekst źródła
16
Niraj, Kinariwala, Samaranayake Lakshman Perera, Perera Irosha i Patel Zeal. "Knowledge, awareness and perceptions of Coronavirus Disease 2019 (COVID-19) in a cohort of indian dental professionals: A questionnaire-based study". STOMATOLOGY EDU JOURNAL 7, nr 4 (2020): 242–51. http://dx.doi.org/10.25241/stomaeduj.2020.7(4).art.2.
Pełny tekst źródłaStreszczenie:
Objectives COVID-19 is an unprecedented global public health emergency currently impacting heavily on India. The objective of this study was to assess the knowledge, awareness, perceptions of Indian dentists on COVID-19. Methods A cross-sectional, on-line questionnaire-based study was conducted amongst 403 Indian dentists in solo, and group practices as well as academics. The self-administered questionnaire assessed 1) knowledge/awareness of factors related to COVID-19 patient identification and symptomatology, 2) knowledge/awareness of COVID-19 transmission and 3) perceptions of COVID-19 history taking procedure. Statistical analyses were conducted using Statistical Package for Social Sciences for Windows, version 21.0 (IBM Corp., Armonk, NY, USA). Frequency distributions and logistic regression analyses were used. Results Indian dentists demonstrated an overall modest level of knowledge on identification of patients with COVID-19. Moreover, they had a high level of awareness of the COVID-19 transmission means, and the generally accepted procedural perceptions on patient history taking. However, there were some gaps in specific aspects of knowledge and perceptions. Those who were aged ≥ 30-years had a significantly higher level of knowledge of patient identification means than those who were < 30-years (OR=1.78:1.12-2.83); p=0.01. Moreover, specialized dentists were significantly more knowledgeable of COVID-19 transmission means than general dentists (OR=1.89:1.22-2.93; p=0.004). Conclusion Our findings demonstrate identifiable gaps in knowledge/awareness and perceptions of COVID-19 in Indian dental professionals. These gaps should be fulfilled, at the earliest, due to the rising burden of COVID-19 in India, to ensure safe dental care delivery.
17
Ghosh, Manimay. "Measuring patient satisfaction". Leadership in Health Services 27, nr 3 (1.07.2014): 240–54. http://dx.doi.org/10.1108/lhs-06-2013-0027.
Pełny tekst źródłaStreszczenie:
Purpose – The purpose of this study was to understand the different dimensions patients staying in a hospital perceived as important for satisfaction and how those dimensions affected their overall satisfaction levels. Design/methodology/approach – A scale comprising 21 items to measure patient experience in a hospital was developed based on literature review. After purification of the scale, a field survey was administered to patients who were discharged in the recent past from a public or a private hospital in the city. The data collected were analyzed using multivariate techniques. Findings – The data analysis highlighted four important dimensions of patient satisfaction. The four dimensions significantly and positively affected patient’s overall satisfaction level. Research limitations/implications – This research study was conducted in one of the four major metropolitan cities of India. Nonetheless, the study provides valuable insights into the patient satisfaction dimensions in an Indian context and how those dimensions affected patient’s overall satisfaction. Practical implications – Hospitals, in general, can use the study findings to measure and improve their operational performance. Originality/value – This study was not limited to one or few hospitals, but covered many hospitals in one of the four metropolitan cities of India. It provides a comprehensive picture of how many hospitals in the city fared in terms of satisfying their patients.
18
Sud, Randhir, Kranthi Kiran Pebbili, Shashank Ashit Desai, Seema Bhagat, Rahul Rathod, Amey Mane i Bhavesh Kotak. "Dyspepsia - The Indian perspective: A cross sectional study on demographics and treatment patterns of Dyspepsia from across India (Power 1.0 study)". Journal of the Association of Physicians of India 71, nr 04 (1.04.2023): 36–46. http://dx.doi.org/10.5005/japi-11001-0231.
Pełny tekst źródłaStreszczenie:
Background: Dyspepsia includes a spectrum of symptoms ranging from epigastric pain and early satiety to postprandial fullness. The worldwide prevalence of dyspepsia is 20–30%. It is slightly higher in the Western population and occurs more frequently among women. While the precise prevalence of dyspepsia in India is not available, different studies estimate that it affects 7.6–49% of the Indian population. Through our current study, we wanted to understand the demographics, clinical profile, patient presentation, and management in India. We also wanted to document the pattern of use of proton pump inhibitors (PPI) and patient satisfaction with PPIs in Indian patients with dyspepsia. Materials and methods: This pan-India, multi-centric, cross-sectional, questionnaire-based, noninterventional, observational study was conducted between February and October 2021 in patients >18 years of age with a clinical diagnosis of any form of dyspepsia. Descriptive statistics were used for categorical variables, and between-group comparisons were made using Fischer’s exact test, with p < 0.05 denoting statistical significance. Results: A total of 3,739 patients from across 29 states of India participated in the study. Most of the patients were male (70.8%) and were from urban areas (56.8%). The highest percentage of patients were aged 31–40 (33.8%), and most patients (60.2%) had dyspepsia for a duration of 6–12 months. Patients with functional dyspepsia (FD) (78.5%) were significantly higher compared to organic dyspepsia (OD) (21.5%) (p < 0.001). The most frequent presenting symptoms were epigastric pain, nausea, vomiting, and heartburn. A quarter (25.6%) of the dyspepsia patients were associated with various comorbid conditions, of which diabetes mellitus, hypertension, and irritable bowel syndrome are the most common ones. A total of 619 patients in the study were on concomitant medications, of which the most common were antidiabetic drugs (271/619, 43.8%). Rabeprazole was the most frequently used PPI (2467/3739, 66.0%) among the study participants. The patient satisfaction analysis showed that, overall, patients were satisfied with PPIs, as most patients (~80%) agreed to almost all questions. The analysis for individual PPIs showed the highest “agree” responses in the rabeprazole group for almost all questions (12 of 13). Around 86.4% of patients on rabeprazole agreed with “immediate relief from acidity,” 84.9% for “gives me complete relief,” and 85.9% for “relief from nighttime acidity symptoms.” Conclusion: Our study involving over 3,700 Indian patients with Dyspepsia adds to the growing knowledge of dyspepsia in India. Dyspepsia is more prevalent in males and in the 31–50 age group. FD is the most common form. Overall, patients were satisfied with PPIs in dyspepsia management in India. Patients on rabeprazole showed higher levels of medication adherence, satisfaction with symptom relief, convenience of therapy, and safety compared to patients on other PPIs. Against the backdrop of a paucity of reliable data about dyspepsia in India, our study results provide valuable insights into Dyspepsia and its management in an Indian setting.
19
Nair, Velu, Satyaranjan Das, Ajay Sharma, Deepak Kumar Mishra, Shilajit Bhattacharya, A. D. Mathur i O. P. Mathew. "Thromboprophylaxis in Multiple Myeloma: Indian Perspective". Blood 112, nr 11 (16.11.2008): 5207. http://dx.doi.org/10.1182/blood.v112.11.5207.5207.
Pełny tekst źródłaStreszczenie:
Abstract Background: Hypercoagulability has been observed in patients of multiple myeloma and has been associated with deep venous thrombosis (DVT). There is growing evidence of increased rate of venous thromboembolism associated with use of thalidomide, an anti angiogenesis drug, especially when combined with other agents such as dexamethasone and doxorubicin. Currently there is no consensus on the most appropriate prophylactic approach for thrombotic episodes in patients of multiple myeloma treated with thalidomide containing regimen. Although newer thalidomide derivatives with less thrombogenic adverse effects are being used in the developed countries, in developing countries like India due to financial constraints thalidomide remains the 1st line drug for multiple myeloma. Further there are scant reports of multiple myeloma related thrombosis and thrombo prophylactic regimen from developing countries. Objectives: To evaluate the incidence of symptomatic as well as asymptomatic thrombosis at onset of the disease as well as during treatment, the efficacy of low dose aspirin and low molecular weight heparin as thromboprophylaxis and their adverse effects in multiple myeloma patients treated with thalidomide and dexamethasone regimen. Patients and Methods: 30 patients of multiple myeloma reporting to our centre from May 2006 to March 2008 comprised the study group. Patient with past history of bleeding, thrombocytopenia and deranged coagulation parameters were excluded from the study. The male to female ratio was 3:2. The median age was 56 years (39–70). 23 patients were de-novo and 7 patients were relapse cases. Before starting therapy in addition to diagnostic and prognostic work up, all patients were evaluated for symptomatic as well as asymptomatic DVT with the help of Color Doppler Flow Index (CDFI) study and d-dimer estimation. Patients were randomized to low dose aspirin (Aspirin 150 mg once a day) and low molecular weight heparin (Enoxapirin 40 mg once a day). All patients were administered dexamethasone pulses of 40 mg once a day from day 1 to 4 in each cycle of 28 days. Thalidomide was started at a dose of 100mg once a day and increased to maximum of 400 mg depending on tolerability (median dose 200 mg). None of the patients received erythropoietin. All patients were evaluated for DVT at the beginning of each cycle during the first three cycles. Thromboprophylaxis was administered for first three cycles only. The response to therapy was evaluated at completion of 3rd and 6th cycles. Criteria for response were as previously reported by Blade et al. Results: The overall response (OR) after 3 cycles was 18/30 (60%), complete response (CR)-10/30(33.3%), partial response (PR)-8/30(26.7%) and after 6 cycles was 22/28 (78.5%), CR-16/28(57.1%), PR-6/28(21.4%). 2 patients who had progressive disease after 3 cycles were changed to Bortezumib containing regimen. Out of 30 patients only one patient (3.3%) a 70 yr old male had deep vein thrombosis at diagnosis which was asymptomatic and the diagnosis was based on CDFI findings. One patient on low dose aspirin had one episode of upper GI bleed on 5th day of the first cycle and thromboprophylaxis was stopped. During the follow up, none of the patient had any evidence of symptomatic as well as asymptomatic DVT. Conclusion: This study suggests that the incidence of venous thrombosis in our cohort of patients were much lower than reported from the west. Both low doses Aspirin as well as low molecular weight heparin are effective agents for thromboprophylaxis. The adverse effects were acceptable. Larger trials would be required to confirm these findings.
20
Churi, Prathamesh, Ambika Pawar i Antonio-José Moreno-Guerrero. "A Comprehensive Survey on Data Utility and Privacy: Taking Indian Healthcare System as a Potential Case Study". Inventions 6, nr 3 (23.06.2021): 45. http://dx.doi.org/10.3390/inventions6030045.
Pełny tekst źródłaStreszczenie:
Background: According to the renowned and Oscar award-winning American actor and film director Marlon Brando, “privacy is not something that I am merely entitled to, it is an absolute prerequisite.” Privacy threats and data breaches occur daily, and countries are mitigating the consequences caused by privacy and data breaches. The Indian healthcare industry is one of the largest and rapidly developing industry. Overall, healthcare management is changing from disease-centric into patient-centric systems. Healthcare data analysis also plays a crucial role in healthcare management, and the privacy of patient records must receive equal attention. Purpose: This paper mainly presents the utility and privacy factors of the Indian healthcare data and discusses the utility aspect and privacy problems concerning Indian healthcare systems. It defines policies that reform Indian healthcare systems. The case study of the NITI Aayog report is presented to explain how reformation occurs in Indian healthcare systems. Findings: It is found that there have been numerous research studies conducted on Indian healthcare data across all dimensions; however, privacy problems in healthcare, specifically in India, are caused by prevalent complacency, culture, politics, budget limitations, large population, and existing infrastructures. This paper reviews the Indian healthcare system and the applications that drive it. Additionally, the paper also maps that how privacy issues are happening in every healthcare sector in India. Originality/Value: To understand these factors and gain insights, understanding Indian healthcare systems first is crucial. To the best of our knowledge, we found no recent papers that thoroughly reviewed the Indian healthcare system and its privacy issues. The paper is original in terms of its overview of the healthcare system and privacy issues. Social Implications: Privacy has been the most ignored part of the Indian healthcare system. With India being a country with a population of 130 billion, much healthcare data are generated every day. The chances of data breaches and other privacy violations on such sensitive data cannot be avoided as they cause severe concerns for individuals. This paper segregates the healthcare system’s advances and lists the privacy that needs to be addressed first.
21
Vijayalakshmi, P., Nagarajaiah, P. Dharma Reddy i B. M. Suresh. "Indian Nurses’ Attitudes Toward Euthanasia". OMEGA - Journal of Death and Dying 78, nr 2 (23.01.2017): 143–60. http://dx.doi.org/10.1177/0030222816688576.
Pełny tekst źródłaStreszczenie:
The debate about euthanasia continues worldwide, with nurses’ attitudes becoming increasingly more important. The aim of this study is to investigate gender differences among nurses’ perceptions of attitudes toward euthanasia. A nonprobability quantitative, cross-sectional design was carried out among nurses working at a tertiary care center. Data were collected through self-reported questionnaires at their work place. Significant differences were found between men and women to the items such as “Fear of death shows differences due to religious beliefs” (χ2 = 10.550, p < 0.05), “If patient wants euthanasia, nutrition support should be stopped” (χ2 = 12.209, p < 0.05), “CPR should not be applied in case of sudden respiration and heart stop” (χ2 = 9.591, p < 0.05), and “burden for relatives to take care of a patient who is in terminal period and who will die” (χ2 = 9.069, p < 0.05). The present study depicts that gender plays an important role in euthanasia; hence, the researchers strongly suggest that there is an urgent need to draft uniform guidelines after wide consultation with all the stake holders regarding nurses’ role in taking care of patients who request euthanasia, to face these situations effectively and competently within professional boundaries.
22
Pooboni, Suneel, Venkat Goyal, Pranay Oza i Poonam Malhotra Kapoor. "ECMO Challenges and Its Future: Indian Scenario". Journal of Cardiac Critical Care TSS 01, nr 02 (grudzień 2017): 89–94. http://dx.doi.org/10.1055/s-0038-1626672.
Pełny tekst źródłaStreszczenie:
AbstractHistory of extracorporeal membrane oxygenation (ECMO) in India dates back to 2001. Initially, ECMO was started for postoperative cardiac cases, but from 2008, it was introduced to intensive critical care unit as a regular practice for refractory cardiogenic shock and acute respiratory distress syndrome. Gradually, the utility of ECMO keeps on increasing such as in poisoning, transplant unit, and even in tracheobronchial surgery. Some centers even started using ECMO for extracorporeal cardiopulmonary resuscitation, even though the data is insufficient. In academic field also, ECMO has had great progress in India with three books and numerous paper presentations by Indian authors, regular conferences, and continued medical education. There were lot of challenges in establishing ECMO in Indian scenario which were addressed successfully; a few challenges are still there which need to be addressed pre-emptively. The most common challenges of ECMO were awareness, cost, initiation at right time, outcome, nosocomial infections, and transport. Transport of critically ill patient, especially on ECMO, is risky and also involves lots of cost. To overcome this problem, flying squad was established in 2010 where the team goes to the hospital where the patient is and initiates and manages ECMO there itself. The future of ECMO in India is quite promising, not only with increasing number of cases and centers, but also in terms of cost-effectiveness and technology.
23
Naik, BSadananda, i Sangram Biradar. "Patient possessiveness among doctors: A unique Indian phenomenon". BLDE University Journal of Health Sciences 6, nr 1 (2021): 109. http://dx.doi.org/10.4103/bjhs.bjhs_90_20.
Pełny tekst źródła
24
Gupta, Somesh, Vishal Gupta, Divya Seshadri, ManeeshKumar Vijay i Puja Sahai. "Dermatomyositis and nasopharyngeal carcinoma in an Indian patient". Indian Journal of Dermatology, Venereology, and Leprology 80, nr 2 (2014): 166. http://dx.doi.org/10.4103/0378-6323.129408.
Pełny tekst źródła
25
Dudani, Pankhuri, Sujay Khandpur i Neetu Bhari. "Sporotrichoid Bowen disease in an immunosuppressed Indian patient". Indian Journal of Dermatology, Venereology and Leprology 87 (1.10.2021): 839–41. http://dx.doi.org/10.25259/ijdvl_959_20.
Pełny tekst źródła
26
Verma, Kaushal K., Shruti Lakhanpal, Cs Sirka, Paschal D'Souza, B. Binod K. Khaitan i Uma Banerjee. "Disseminated mucocutaneous blastomycosis in an immunocompetent Indian patient". Journal of the European Academy of Dermatology and Venereology 14, nr 4 (lipiec 2000): 332–33. http://dx.doi.org/10.1046/j.1468-3083.2000.00097-14.x.
Pełny tekst źródła
27
Dahale, A., L. Sherine i S. K. Chaturvedi. "In-patient suicide in psychiatry – an Indian experience". Epidemiology and Psychiatric Sciences 26, nr 5 (30.03.2017): 565–69. http://dx.doi.org/10.1017/s2045796017000129.
Pełny tekst źródła
28
Nugent, Jeffrey S., Kevin E. O’Brien, Mark Harris i Chandra Mohan. "Paget’s Disease of Bone in an Indian Patient". JCR: Journal of Clinical Rheumatology 8, nr 4 (sierpień 2002): 212–16. http://dx.doi.org/10.1097/00124743-200208000-00009.
Pełny tekst źródła
29
Dharmanand, Balebail Gopalakrishna. "Patient perspective in rheumatology outcome measures – Indian perspective". Indian Journal of Rheumatology 8 (grudzień 2013): S23. http://dx.doi.org/10.1016/j.injr.2013.11.003.
Pełny tekst źródła
30
Thounaojam, Romita, Leader Langbang, Kavish Itisham, Roohollah Sobhani, Shivani Srivastava, Bhargavi Ramanujam, Ramesh Verma, Manjari Tripathi i Kripamoy Aguan. "EFHC1 mutation in Indian juvenile myoclonic epilepsy patient". Epilepsia Open 2, nr 1 (1.02.2017): 84–89. http://dx.doi.org/10.1002/epi4.12037.
Pełny tekst źródła
31
Ekbote, Alka Venkatesh, Kausik Mandal, Indira Agarwal, Rajiv Sinha i Sumita Danda. "Fanconi- Bickel Syndrome: Mutation in An Indian Patient". Indian Journal of Pediatrics 79, nr 6 (5.10.2011): 810–12. http://dx.doi.org/10.1007/s12098-011-0568-9.
Pełny tekst źródła
32
Jegatha, C., i V. Hemavathy. "Effectiveness of health education on behaviour on diabetic care among rural adult diabetic patients -- a pilot analysis". CARDIOMETRY, nr 26 (1.03.2023): 653–57. http://dx.doi.org/10.18137/cardiometry.2023.26.653657.
Pełny tekst źródłaStreszczenie:
Diabetes claims the lives of about one million Indians each year. According to the Indian Heart Association, the number of people diagnosed with diabetes in India would rise the most by 2030. The increasing frequency is linked to a combination of genetic vulnerability and the growing middle class in India's adoption of a high-calorie, low-activity lifestyle. Pretest, patients had 7.88behaviour score and in posttest they had 12.00behaviour score, like a result, the average score difference is4.12, difference is huge and it is statistically significant behaviour gain score, The student's paired 't'test was used to determine statistical significance. The relationship between post-test behaviour and patient demographic characteristics. Above primary level educated patients and>10 years duration of illness patients are having more favorable behavior score than others. It was confirmed using chi square test and Yates corrected chi square test. This study concludes by proving the effectiveness of health education on behaviour on diabetic care among diabetic patients
33
Prabhash, Kumar, Amit Rauthan, Senthil Rajappa, Chirag Desai, Rajesh Mistry, Amit Dutt, Anuradha Chougule i in. "Feasibility of molecular testing in a multicenter study with geographical variation in India: Epidermal growth factor receptor mutation as a model molecular test". Asian Journal of Oncology 03, nr 01 (styczeń 2017): 039–44. http://dx.doi.org/10.4103/asjo.asjo_104_16.
Pełny tekst źródłaStreszczenie:
AbstractContext: Trends in epidermal growth factor receptor (EGFR) mutation based on ethnicity assist the initial selection of targeted therapy regimen. Reported incidence of EGFR mutation in Indian NSCLC patients is variable, ranging from 22% to 51.8%.Aim and Settings and Design: This multicenter, noninterventional study evaluated the prevalence of EGFR mutation in Indian NSCLC patients, its association with patients’ demographics, and for the first time used a central laboratory for molecular testing.Subjects and Methods: Tissue samples from 252 NSCLC patients were tested at a Central Laboratory at Tata Memorial Hospital. Statistical Analysis Used: Patient demographics, baseline characteristics including smoking status from routine examination were recorded in a single visit. Chi-square or Fisher's exact test was used for association of EGFR mutation status with gender, age, smoking status, and histological subtypes.Results: The prevalence of EGFR mutation in Indian NSCLC patients was 23.4%. Among these, 55.9% patients had mutations in exon 19, 39% in exon 21, and 1.7% in exon 18. The incidence of EGFR mutation was higher in females than males (32.5% vs. 18.9%, respectively), and in 30.6% patients that had never smoked, 26.3% smokers, and 5.8% former smokers. The mean duration of transportation of tissue samples to the central laboratory was 48 h with an average turnaround time of 5 days for molecular testing.Conclusions: Molecular testing at a central laboratory is a feasible option in India. Prevalence of EGFR mutation in Indian NSCLC patients was similar across western and southern centers in India. A statistically significant association between EGFR mutation and gender as well as the smoking status of the patients was observed. Majority of the patients had in-frame deletions in exon 19.
34
Padma, Panchapakesan, Prakash Sai Lokachari i Rajendran Chandrasekharan. "Strategic action grids: a study in Indian hospitals". International Journal of Health Care Quality Assurance 27, nr 5 (3.06.2014): 360–72. http://dx.doi.org/10.1108/ijhcqa-11-2012-0108.
Pełny tekst źródłaStreszczenie:
Purpose – The purpose of this paper is to provide strategic recommendations to Indian hospital administrators for improving service quality by analysing performance dimensions and the importance attached to them by patients and attendants. Design/methodology/approach – Patient and attendant perceptions were collected using a questionnaire. Findings – Patients and attendants have different perceptions. Different customers have different needs of which providers need to be aware to better serve their consumers. Research limitations/implications – The study captured only 408 patient and attendants’ perceptions – a 32 per cent response rate. Practical implications – Results enable hospital administrators to develop appropriate strategies to improve their structure and function by analysing their strengths and weaknesses regarding their tangible and intangible assets. Originality/value – The study included attendants, specifically in an Indian healthcare context.
35
SriKrishna, Srikakulapu. "Heart Failure in a Patient with Leprosy". Indian Journal of Cardiovascular Disease in Women WINCARS 04, nr 03 (sierpień 2019): 150–52. http://dx.doi.org/10.1055/s-0039-3399618.
Pełny tekst źródłaStreszczenie:
AbstractLeprosy, also known as Hansen's disease, is a chronic infection caused by the bacteria Mycobacterium leprae and Mycobacterium lepromatosis. Though leprosy predominantly involves peripheral nerves and skin, visceral involvement was recognized as early as 1894 by Hansen and Looft. It is known that the bacilli can lie dormant in some tissues of the body long after the skin smears have become negative. We describe a case of leprosy in an Indian male who presented to us with heart failure. This is likely the first report of showing the possible association of leprosy with heart failure from India. The cardiovascular involvement in leprosy is briefly reviewed.
36
Dranitsaris, George, Ilse Truter, Martie S. Lubbe, Nitin N. Sriramanakoppa, Vivian M. Mendonca i Sangameshwar B. Mahagaonkar. "Improving patient access to cancer drugs in India: Using economic modeling to estimate a more affordable drug cost based on measures of societal value". International Journal of Technology Assessment in Health Care 27, nr 1 (styczeń 2011): 23–30. http://dx.doi.org/10.1017/s026646231000125x.
Pełny tekst źródłaStreszczenie:
Background: Using multiples of India's per capita gross domestic product (GDP) as the threshold for economic value as suggested by the World Health Organization (WHO), decision analysis modeling was used to estimate a more affordable monthly cost in India for a hypothetical new cancer drug that provides a 3-month survival benefit to Indian patients with metastatic colorectal cancer (mCRC).Methods: A decision model was developed to simulate progression-free and overall survival in mCRC patients receiving chemotherapy with and without the new drug. Costs for chemotherapy and side-effects management were obtained from both public and private hospitals in India. Utility estimates measured as quality-adjusted life-years (QALY) were determined by interviewing twenty-four oncology nurses using the Time Trade-Off technique. The monthly cost of the new drug was then estimated using a target threshold of US$9,300 per QALY gained, which is three times the Indian per capita GDP.Results: The base-case analysis suggested that a price of US$98.00 per dose would be considered cost-effective from the Indian public healthcare perspective. If the drug were able to improve patient quality of life above the standard of care or survival from 3 to 6 months, the price per dose could increase to US$170 and US$253 and offer the same value.Conclusions: The use of the WHO criteria for estimating the cost of a new drug based on economic value for a developing country like India is feasible and can be used to estimate a more affordable cost based on societal value thresholds.
37
Dasbiswas, Arup, Samir Kubba i Jossy Chacko. "Experts’ consensus: pharmaco-invasive therapy for ST‐elevation myocardial infarction along with focus on secondary prevention and cardiac rehabilitation in India". International Journal of Advances in Medicine 8, nr 2 (27.01.2021): 325. http://dx.doi.org/10.18203/2349-3933.ijam20210286.
Pełny tekst źródłaStreszczenie:
In India, patients with acute coronary syndrome (ACS) tend to present with higher percentage of ST-elevation myocardial infarction (STEMI). Numerous existing challenges like patient unawareness, lack of structured STEMI care systems, inadequacy of promptly available facilities and unequipped ambulances for patient transport make it difficult to achieve optimal STEMI treatment. Also, due to socio-economic diversities prevailing in India, a large proportion of the entire population has access to only basic primary healthcare and are unable to afford proper medical facilities. Judicious and timely reperfusion strategy has been the mainstay of STEMI management. Even though, percutaneous coronary intervention (PCI) continues to be the gold standard for treating STEMI worldwide, it is not the ideal strategy in many Indian settings, especially in villages and smaller towns/cities. In such scenarios, pharmaco-invasive approach has proved to be a better reperfusion therapeutic strategy for improving treatment outcomes and subsequently reducing morbidity and mortality. The purpose of this consensus article is to highlight the clinical perspectives of Indian cardiologists at identifying and addressing the need gaps currently existing in India for optimization of STEMI treatment approaches. The experts shared their views on the rationale of pharmaco-invasive approach and highlighted the significance of commonly used thrombolytic agents, STEMI treatment protocols, secondary prevention and cardiac rehabilitation.
38
Chandran, Viji Pulikkel, Sohil Khan, Girish Pai Kulyadi, Elsa Sanatombi Devi i Girish Thunga. "Evidence based medicine and pharmacy curriculum: an insight into Indian perspective". Bangladesh Journal of Medical Science 19, nr 4 (12.04.2020): 603–8. http://dx.doi.org/10.3329/bjms.v19i4.46613.
Pełny tekst źródłaStreszczenie:
World Health Organization recommends doctor population ratio as 1: 1000 and in India the ratio is 0.62: 1000. With the ever growing population and tremendous patient pool in India the significant challenge faced by clinicians is lack of skilled allied health professionals who can assist in providing timely, unbiased, critically appraised health information. Pharmacists are the most accessible health professionals and thereby crucial in facilitating rational medication usage and working closely with the public and multidisciplinary health care team. The goal of patient care can be achieved through the focused skill development programs embedded in health students’ curriculum. Indian pharmacy curriculum should be fostered with inclusion of evidence based medicine focused training programs, workshops, case studies, digital stories, e - pocket cards and simulations. This article represents current status of evidence based medicine learning and teaching in Indian pharmacy curriculum.
Bangladesh Journal of Medical Science Vol.19(4) 2020 p.603-608
39
Joseph, Sharmila Mary. "Patients versus Patents: The Indian Supreme Courts Decision in the Novartis Case". Global Trade and Customs Journal 8, Issue 7/8 (1.07.2013): 239–46. http://dx.doi.org/10.54648/gtcj2013033.
Pełny tekst źródłaStreszczenie:
The Indian Supreme Court in a landmark judgment on 1 April 2013 dismissed the plea of Novartis AG for grant of patent for the beta crystalline form of Imatinib mesylate. The Court did not find the product to have satisfied the relevant provisions of patentability laid down in the Indian Patents Act. Patents for pharmaceutical products have always triggered intense debate in India and other developing countries. The Indian Patent laws are fully compliant with the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS Agreement). This article through the lens of the Court verdict analyses whether there was any real enhancement in therapeutic efficacy of the product as claimed by Novartis and whether Novartis resorted to evergreening. The article dwells on the possible implications of the judgment on investments in India; and innovations in research and development in the pharmaceutical sector. The article further observes that the Court has, while upholding the public health agenda of the state, judiciously interpreted the statutory provisions governing the grant of intellectual property rights for pharmaceutical products in India, in the patient versus patent debate.
40
Kaur, Sukhpreet, Rajinder Kaur i Rashmi Aggarwal. "E-health and its Impact on Indian Health Care: An Analysis". Paradigm 23, nr 2 (7.08.2019): 164–74. http://dx.doi.org/10.1177/0971890719859943.
Pełny tekst źródłaStreszczenie:
Healthcare sector is progressing towards digitalization in every aspect such as e-consultations, health surveillance, health education and various other healthcare services. Developing countries like India lacks infrastructure to conduct studies to evaluate impact of these e-health services on patient outcomes. Various developed countries have electronic health records which makes evaluation of patient outcomes much easier. This paper aims to evaluate effect of e-health on patient outcomes in Indian healthcare scenario and future consequences of these e-health services. The integrative literature searches were conducted using various databases such as pubmed, google scholar and SCC web edition using keywords such as ‘e-health’, ‘telemedicine’, ‘mhealth’, ‘electronic health records’, ‘patient outcomes’ and ‘data protection laws’. From the papers retrieved only few papers studied impact of e health services in patient outcomes. Other papers assessed e-health on basis of accessibility, feasibility and medium of education in clinical practice. It was concluded that e-health services such as diagnostic services like teleopthalmology and tele ECG, distant consultation with specialist through telemedicine and adherence aids like automated voice reminder and pictorial messaging have positive impact on patient outcomes. Though e-health services can help us in various ways but it will also open the new Pandora box of problems in handling personal information. The information technology rules in India have certain grey areas in protection of digital data. In future, besides improving the data content of information system to analyse the impact of various services provided to the patients, we will have to relook the legal system to protect the data.
41
P, Mathew. "Autoimmune Hepatitis-Profile and Response to Treatment in Indian Patients". Gastroenterology & Hepatology International Journal 4, nr 2 (22.07.2019): 1–6. http://dx.doi.org/10.23880/ghij-16000159.
Pełny tekst źródłaStreszczenie:
Introduction: Autoimmune hepatitis (AIH) can have varied manifestations, commonest presentation being as chronic liver disease. The data on the disease profile in India is scanty compared to the West. Aim: To study the clinical, biochemical, histological profile and response to treatment in patients with Auto-immune Hepatitis in Indian population. Methods: This is a Retrospective analysis of the twenty one (12 M = 57.1%; 9 F = 42.9%) patients diagnosed with AIH according to simplified criteria for diagnosis of AIH, in the last three years (2017-2019) in the department of medical gastroenterology, Vydehi Institute of Medical Sciences, Bangalore, Karnataka, India. Results: AIH accounted for 4.3% of all the liver diseases diagnosed during the last three years. Incidence of AIH was higher in males (12 M = 57.1%; 9 F = 42.9%; male to female ratio was 1.3:1), most common presenting symptom was jaundice, sixteen (57.1%), followed by ascites seven (33%) patients. Extra-hepatic manifestation was seen in fourteen (66.7%) patients. Eleven (52.3%) patients had cirrhosis with four (19%) patients having compensated cirrhosis, five (23.8%) patients having de-compensated cirrhosis, two (9.5%) patients presenting with features of acute on chronic liver failure, two (9.5%) patients presenting with acute hepatitis and seven (33.3%) patients presenting with features of chronic hepatitis. Nineteen (91%) patients had Type I AIH, one (4.5%) patient had Type II AIH and 1 patient had seronegative AIH. Oral budesonide was started in 11(52%) of patients, 8(38%) were started on oral prednisolone and 2(10%) patients were started on intravenous methyl prednisolone in view of severe auto-immune hepatitis. Azathioprine was added in 19 patients and dose was modified according to the clinical response and side effects. Four (21.05%) patients developed drug intolerance, out of which one patient had severe adverse effect in the form of acute pancreatitis secondary to Azathioprine. Mycophenolate Mofetil (MMF) was given with good response. Mortality was noted in two (9.52%) patients.
42
Ullrich, Helen E. "Culture, Empathy, and the Therapeutic Alliance". Psychodynamic Psychiatry 50, nr 1 (marzec 2022): 151–64. http://dx.doi.org/10.1521/pdps.2022.50.1.151.
Pełny tekst źródłaStreszczenie:
When the therapist and patient are from different cultures, there may be impediments to the development of empathy and a therapeutic alliance. South India culture provides an example of contrasting values and customs about which patients may be reluctant to discuss. The initial case history is of a South Indian who sought treatment in the United States. The remaining cases, drawn from a village in South India with which the author has had a 55-year history of research, illustrate cultural factors potentially inhibiting or facilitating the development of empathy and a therapeutic alliance.
43
Mehra, Payal. "Does Consultation Time Influence Patient Perception of Provider Communication Style, Patient Satisfaction, and Word of Mouth Recommendation in India? A mediation analysis". Asia Pacific Journal of Health Management 13, nr 1 (30.05.2018): i26. http://dx.doi.org/10.24083/apjhm.v13i1.31.
Pełny tekst źródłaStreszczenie:
Background: In medically underserved developing countries such as India, the length of the consultation is often compromised; providers, it appears, have lost their natural empathetic tendencies and try to substitute talk with techniques and procedures. Despite this, surprisingly, patient satisfaction is high in India. This raises questions on the importance of understanding how patients feel about the clinical consultation length and the way it affects their satisfaction. In this context, this study analysed if the time spent with the patient predicted different changes to patient satisfaction with the provider and word of mouth recommendation.Methods: This cross sectional study comprised a sample of working Indian adults (N=501), completing communication competence measures and indicating their satisfaction and word of mouth recommendation potential. The four step Baron and Kenny’s model of mediation analysis, apart from the GLM and factor analysis, was used for the analysisResults: Findings showed that the communication style of the providers positively influenced the health outcomes such as patient satisfaction and word of mouth recommendation, and the length of direct consultation time mediated this relationship. Gender wise, male patients were more likely to complain about poor communication competency of the providers and less consultation time than female patients Conclusion: We conclude that patients positively associate a longer clinical consultation time with empathetic and competent providers and be willing to recommend him/her to others. However due to extreme paucity of qualified providers in India, patients generally ignore or suffer problems related to time or communication style.
44
Chauhan, Dr Amit. "Acral Persistent Papular Mucinosis in Indian Patient: Rare Presentation with Review of Literature". Journal of Medical Science And clinical Research 05, nr 02 (2.02.2017): 17316–20. http://dx.doi.org/10.18535/jmscr/v5i2.14.
Pełny tekst źródła
45
Pandey, Krishna, Dharmendra Singh i Pradeep Das. "Lipodystrophy in an Immuno-compromised Indian Patient with Pulmonary Tuberculosis and Brain Tuberculoma". Indian Journal of Applied Research 4, nr 6 (1.10.2011): 390–91. http://dx.doi.org/10.15373/2249555x/june2014/122.
Pełny tekst źródła
46
Shenoy, Dinesh. "INDIAN PHARMA INDUSTRY – WHAT’S NEXT?" INDIAN DRUGS 55, nr 10 (28.10.2018): 5–6. http://dx.doi.org/10.53879/id.55.10.p0005.
Pełny tekst źródłaStreszczenie:
Dear Reader, I am honored to contribute this Editorial feature for the Indian Drugs. The timing couldn’t have been better – as our industry is poised at the inflection point to takeup the next challenge. Let me start with two exciting stories related to innovation in the pharmaceutical industry: one related to a break-through innovation and the other related to an incremental, yet very important innovation. First, the break-through innovation. KYMRIAHTM (Tisagenlecleucel suspension for intravenous infusion; innovator – Novartis) became the first chimeric antigen receptor T cell (CAR-T) therapy to receive regulatory (US-FDA) approval in August-2017 for the treatment of patients up to 25 years of age with B-cell precursor acute lymphoblastic leukemia that is refractory or in second or later relapse. In May-2018, it received approval for the second indication by US-FDA – the treatment of adult patients with relapsed or refractory (r/r) large B-cell lymphoma. KYMRIAHTM has become a landmark product in the field of personalized and transformative medicine – wherein the product is manufactured individually for each patient using the patient’s own T cells.
47
Fernandes, Alphonsa B., Sweta D'Cunha i Sucharita Suresh. "Patient Rights: Awareness and Practice in a Tertiary Care Indian Hospital". International Journal of Research Foundation of Hospital and Healthcare Administration 2, nr 1 (2014): 25–30. http://dx.doi.org/10.5005/jp-journals-10035-1011.
Pełny tekst źródłaStreszczenie:
ABSTRACT Aim and objectives To study the awareness and practice of Patient rights and to compare the same between general and private ward hospitalized patients of a selected hospital. Materials and methods Descriptive research approach was adopted wherein data was collected from 120 hospitalized patients, i.e. 60 from general and 60 from private ward using a structured questionnaire. It was then analyzed by frequency, percentage and significance test to interpret the awareness and practice of patient rights in the hospital. Results The study reveals that awareness of patient rights was high in most of the cases. There was 71% awareness about the right to confidentiality, 67% awareness of the right to grievance redressal, 65% awareness about the right to be informed, 58% awareness of the right of access to healthcare and 55% awareness about the patient's right to choice of care and decision making. But low (39%) awareness was noted in case of patient's right to informed consent. With regards to practice of patient rights, it was seen that certain rights were well-practiced like 95% practice of the right of access to healthcare, 89% practice of the right to confidentiality and 64% practice of the right to choice of care and decision making. But relatively lower percentage of practice was observed for right to be informed (49%), right to informed consent (44%) and the right to grievance redressal (21%). There was significant difference in the level of awareness and practice of patient rights among private and general ward patients in most of the rights. Conclusion The study was vital in finding that most respondents were aware of patient rights. So also, most of the patient rights were practiced in the hospital in varying degrees, while a few needed immediate rectification and management action. How to cite this article Fernandes AB, D'Cunha S, Suresh S. Patient Rights: Awareness and Practice in a Tertiary Care Indian Hospital. Int J Res Foundation Hosp Healthc Adm 2014;2(1):25-30.
48
Basu, Anindansu, i Deb Kumar Majumder. "The Indian telemedicine challenge: in current evolving pandemic". International Journal Of Community Medicine And Public Health 8, nr 9 (27.08.2021): 4646. http://dx.doi.org/10.18203/2394-6040.ijcmph20213580.
Pełny tekst źródłaStreszczenie:
The unparalleled Coronavirus disease 2019 (COVID-19) outburst has ushered a radical change in the conventional healthcare industry in India. The unprecedented lockdown and the ongoing COVID crisis has reincarnated telemedicine practice for the unforeseeable future. The Indian government was quick to realise it and laid guidelines for its practice across video, audio, or text. The teleconsultation is basically doctor-patient interaction bridged by information technology over an online platform to receive essential health-care services. All doctor-patient relationships thrive on mutual trust which is hardly established over first time virtual consultation considering the emotions of the majority of Indian population and its inertia to change. The medical fraternity though initially uncomfortable with these changes are slowly adapting to this new reality over the last one and half years. The recent guidelines, 2020 have bestowed full onus on the doctor as to decide whether tele-consultation is sufficient or is in-patient evaluation required based on patient complexities. But if any untoward event, delay to urgent care or malpractice happens out of this, will the doctor be held responsible and if yes, is it going to be covered under medical indemnity? Moreover, telemedicine platform being a mix of medical sciences and information technology is governed by laws of both making it complicated, with a steep learning curve for all concerned. Besides the right to privacy is fundamental in medical ethics and stands undebated in telemedicine too. The responsibility of harbouring and protecting the information rests primarily on the doctor. But there is till date no regulatory body that authorises the tech platforms with specific legislations and regulations making seepage of sensitive and personal data and information (SPDI) a certain possibility. In the western world any platform that deals with protected health information (PHI) must be Health Insurance Portability and Accountability Act (HIPAA) compliant ensuring data security, unlike India. The more telemedicine gains traction and computerised operations are being used to keep tag of digital health records, radiology, pharmacy and laboratory systems, security concerns will proportionately increase. Additionally, the technology platforms have been given the rights to analyse the credibility of the doctors and regulate consultation fees with no government monitoring inviting probable disastrous consequences. They at times act as middlemen between the doctor, pharmacies, laboratories and patients serving their own vested interests. They often advertise promotional offers to lure in patients flouting all moral ethics for business/to increase their market share. Additionally their terms and conditions and grievance section are framed mostly in a way that the doctor eventually becomes the scapegoat in any untoward development. Apprehending these potential loopholes, the U.S.A has passed The Health Information Technology for Economic and Clinical Health (HITECH) Act (2009) to maintain vigilance over ePHI security, offsite backup in IT failure, methods of data storage and transfer as per HIPAA standards and to penalise in case of defaulters. On the other hand currently there is no formalised policy for insurance reimbursement like most developed nations. The current pandemic push has bolstered the telemedicine growth and the market share is expected to cross $5.5 billion by 2025 in India. But for successful integration of telemedicine with normal practice in future one needs to define and compartmentalise the role of doctors and tech platforms with comprehensive legislations so that medical decisions are taken not based on personal interests but for optimal patient care. Otherwise in the quest for a new avatar in Indian healthcare system we might just end up creating another Frankenstein's monster.
49
Kandhari, Sanjeev, P. Narasimha Rao, Shehnaz Arsiwala, Anil Ganjoo, Seema Sood i Dinesh Kumar. "Expert opinion on current trends in hyperpigmentation management: Indian perspective". International Journal of Research in Dermatology 8, nr 1 (24.12.2021): 142. http://dx.doi.org/10.18203/issn.2455-4529.intjresdermatol20214925.
Pełny tekst źródłaStreszczenie:
<p class="abstract">Hyperpigmentation is a common pigmentary disorder characterized by increased production of melanin. It is present in Asian skin phototypes, with a higher prevalence in the Indian population. Skin heterogeneity is seen in more than 80% of individuals of all age groups and genders in several cities across India. In children, the prevalence of hyperpigmentary disorders accounts for 1.54 per 1000 children.Sixty expert dermatologists participated in expert group meetings via teleconference webinar to elaborate on the current trends in the management of hyperpigmentary disorders. The major reasons for hyperpigmentary disorders in India include melanocyte function followed by exposure to ultraviolet radiation, race, ethnicity, use of medications, pregnancy, and use of cosmetic. There are wide varieties of skin-lightening or depigmenting agents and skin resurfacing procedures that aid in the management of hyperpigmentation. However, treatment becomes challenging due to compliance issues related to affordability, complexity of prescriptions, and treatment duration. Compliance increases only if the patient sees any improvement or discontinues treatment due to higher expectations. Hence, the success of the treatment lies in patient adherence. This article summarizes expert opinions on identifying, diagnosing, and managing hyperpigmentation with the help of topical depigmenting agents in the Indian scenario. It also emphasizes treatment adherence issues along with the role of patient counseling and education regarding disease awareness and treatment strategies.</p>
50
Milind Abhimanyu Nisargandha i Shweta DadaraoParwe. "Spread of coronavirus disease 2019 (COVID-19) during the lockdown in the Indian population and preventive measures". International Journal of Research in Pharmaceutical Sciences 11, SPL1 (4.08.2020): 328–32. http://dx.doi.org/10.26452/ijrps.v11ispl1.2721.
Pełny tekst źródłaStreszczenie:
Coronavirus disease 2019 (COVID -19) is the newly found virus in Indian population spreading all over the world through the seafood market of Wuhan, Hubei, China. Due to the spreading of coronavirus in Indian Government facing difficulty after the lockdown of one month in two phases, the number of patients is increased day by day. This is a very challenging task for the Indian Government, people are not strictly following the guidelines of the World Health Organisation. In India reported 26585 confirmed cases and 833 deaths due to COVID -19 in 31 states and union territories when the first case was found on 30th January 2020. The Government decided immediately to lockdown and closed all international borders, as per the WHO guidelines for a pandemic. The future directions to choose for people can fight with such type of pandemic. The present reviewemphasis is strictlyon the WHO guideline's to prohibit spreading coronavirus in India. There is some gap of awareness in people which enhance spreading coronavirus even during the lockdown. This finding has cause to concern about the spread of coronavirus in thisscenarioduring the lockdown, what farther primary prevention to be taken to avoid such transmission. The lockdown is already having a beneficial impact of flattening the epidemic curve for spreading this transmission and During Lockdown period in each state. Each state having sufficient time for finding COVID -19 Patient, people come in contact with the patient keeps them institutional isolation and declared that area infection hotspot at the district level.